SEC Form 4/A · accession 0001104659-15-054453
SUPERNUS PHARMACEUTICALS, INC. · SUPN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Stefan K.F. Schwabe
Officer — Executive Vice President R&D
Period of report
Jul 13, 2015
Accepted (ET)
Jul 29, 2015 · 6:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001356576
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jul 13, 2015 | S | 1,950 | $19.23 | D | 2,350 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Transaction made pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2015.
- F2The Reporting Person is amending the Form 4 filed on July 14, 2015 to reflect the fact that the number of securities owned after the reported transaction includes an aggregate of 1,506 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan subsequent to the date of the Reporting Person's most recent filing on Form 4.